Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Newborn screening for hypophosphatasia: development of a high-throughput tissue nonspecific alkaline phosphatase activity assay using dried blood spots. | JBMR Plus | 2025 | 39925621 | PubTator, text mining | PubMed |
| Infantile hypophosphatasia: a rare aetiology of recurrent pneumonia. | BMJ Case Rep | 2025 | 39922572 | PubTator, text mining | PubMed |
| Vdr mediates Wnt signaling pathway to regulate odontoblasts differentiation during dentin apposition. | Eur J Pharmacol | 2025 | 39894431 | PubTator, text mining | PubMed |
| Ionic silver coating of orthopedic implants may impair osteogenic differentiation and mineralization. | Exp Ther Med | 2025 | 39885915 | PubTator, text mining | PubMed |
| Efficacy of asfotase alfa in a patient with adult-onset hypophosphatasia without obvious bone lesions: a case report with review of literature. | Endocr J | 2025 | 39880615 | PubTator, text mining | PubMed |
| Dental manifestations of hypophosphatasia: translational and clinical advances. | JBMR Plus | 2025 | 39872235 | PubTator, text mining | PubMed |
| Adult hypophosphatasia presenting with recurrent acute joint pain. | Endocrinol Diabetes Metab Case Rep | 2025 | 39868560 | PubTator, text mining | PubMed |
| Deciphering the Transcriptional Metabolic Profile of Adipose-Derived Stem Cells During Osteogenic Differentiation and Epigenetic Drug Treatment. | Cells | 2025 | 39851564 | PubTator, text mining | PubMed |
| CASR, CLDN 14, ALPL & SLC34A1 genes are associated with the risk of nephrolithiasis in Egyptian children. | J Pediatr Urol | 2025 | 39788827 | PubTator, text mining | PubMed |
| Single-nucleus transcriptome profiling provides insights into the pathophysiology of adhesive arachnoiditis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39755217 | PubTator, text mining | PubMed |
| A NOTCH3 pathogenic variant influences osteogenesis and can be targeted by antisense oligonucleotides in induced pluripotent stem cells. | PLoS One | 2025 | 39752389 | PubTator, text mining | PubMed |
| A xenogenic-free culture medium for cell micro-patterning systems as cell-instructive biomaterials for potential clinical applications. | Biomed Mater | 2025 | 39719129 | PubTator, text mining | PubMed |
| Diagnosis, treatment, and follow-up of patients with hypophosphatasia. | Endocrine | 2025 | 39663303 | PubTator, text mining | PubMed |
| The effect of osteoclasts on epigenetic regulation by long non-coding RNAs in osteoblasts grown on titanium with nanotopography. | Biomater Adv | 2025 | 39622096 | PubTator, text mining | PubMed |
| A case study of hypophosphatasia: An underdiagnosed bone disorder characterized by low alkaline phosphatase. | J Am Assoc Nurse Pract | 2025 | 39591362 | PubTator, text mining | PubMed |
| Circ_0003072 Mediates the Pro-osteogenic Differentiation Effect of Betulinic Acid on Human Periodontal Ligament Stem Cells. | Int Dent J | 2025 | 39572284 | PubTator, text mining | PubMed |
| A NOTCH2 pathogenic variant and HES1 regulate osteoclastogenesis in induced pluripotent stem cells. | Bone | 2025 | 39571704 | PubTator, text mining | PubMed |
| Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease. | JAMA Cardiol | 2025 | 39504041 | PubTator, text mining | PubMed |
| Effects of icariin on dental pulp stem cells and its potential applications in dentin repair. | Arch Oral Biol | 2025 | 39437662 | PubTator, text mining | PubMed |
| Modulation of regenerative responses by retinoic and ascorbic acids in human apical papilla cells. | Arch Oral Biol | 2025 | 39357392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=11